FibroBiologics Stock Surges 82% on Data Presentation and SEC Filing
FibroBiologics Stock Surges 82% on Data Presentation and SEC Filing
Photo by ismagilov Investors cheered on Tuesday as the stock of newly public FibroBiologics (NASDAQ:FBLG) surged 82% following the company’s release of preclinical data and its announcement of a private placement of 65,447 shares at $15 per share. Opening at $7.70 and later hitting a high of $15.47, the stock ultimately closed at $13.45, marking ...












